COVID-19: Pfizer sought approval Friday to FDA for coronavirus vaccine – preparations to bring COVID-19 vaccine to US soon, Pfizer seeks permission from FDA

Preparing to bring COVID-19 vaccine to US soon, Pfizer asks FDA permission

File photo


In the midst of the coronavirus epidemic, various countries around the world are developing COVID-19 vaccine. Many vaccines are in the final stages. Meanwhile, US giant biotech company Pfizer and its German partner BioNTech on Friday sought permission from the US administration to introduce the Corona virus vaccine soon. This is believed to be the first step in the direction of relief in the wake of the re-emergence of conditions and the slowdown in the global economy due to the rise of Corona in various countries.

Also read

In the era of Corona virus crisis, the world is looking towards scientists to get rid of global epidemic. The US Food and Drug Administration (FDA) said its vaccine committee will meet on December 10 to consider a request for emergency use clearance. Stephen Han, the head of the organization, said, “The FDA believes that dialogue and transparency are necessary to build people’s trust in the COVID-19 vaccine.”

“I want to assure the American people that the FDA’s process and evaluation of data for a potential COVID-19 vaccine will be as open and transparent as possible,” he said. He said that he could not guess how long the review would take. However, the US government says that the vaccine may be approved in December.

Recently pharmaceutical major Pfizer said that in the final analysis the COVID-19 vaccine was found to be 95% effective and the company says that it will apply for the necessary approval within a day.



Please enter your comment!
Please enter your name here